Latest information on
Skip to Content
Skip to Local Navigation
Skip to Global Navigation
Explore Stanford Medicine
Find a doctor
Pediatrician or pediatric specialist
Clinics & Services
Basic science departments
Clinical science departments
See full directory
Clinical research fellows
Continuing Medical Education
Residencies & fellowships
High School & Undergraduate Programs
Basic science departments
Clinical science departments
Support teaching, research, and patient care.
Ways to give
Why giving matters
Make a gift online
Maps & directions
How you can help
Submit Search Query
Oliver Dorigo, M.D., Ph.D.
Associate Professor of Obstetrics and Gynecology (Oncology)
Cancer > Gynecologic Cancer
Associate Professor - University Medical Line,
Obstetrics & Gynecology - Gynecologic Oncology
Stanford Cancer Institute
Director, Stanford Gynecologic Oncology Fellowship (2016 - Present)
Director, Stanford Clinical Research Group for Gynecologic Cancer Trials (2014 - Present)
Director, Stanford Gynecologic Oncology Clinical Care Program (2013 - Present)
Director, Mary Lake Polan Gynecologic Oncology Research Laboratory (2013 - Present)
Director, Stanford Obstetrics and Gynecology, Division of Gynecologic Oncology (2013 - Present)
Honors & Awards
American Association of Cancer Research Outstanding Poster Award, Toronto, Canada, American Association of Cancer Research, Toronto, Canada (1995)
Outstanding Podium Presentation Award, National Gynecologic Oncology Fellow’s Forum (2004)
Teaching Award, National Council on Resident Education in Obstetrics and Gynecology (2007)
STOP Cancer Career Development Award, STOP Cancer (2008)
OB/GYN Resident Teaching Award, University of California, Los Angeles (2008)
Boards, Advisory Committees, Professional Organizations
Member, Society of Pelvic Surgeons (2016 - Present)
Member, American Association of Cancer Research (1996 - Present)
Member, American Gynecological and Obstetrical Society (2016 - Present)
Member, Society of Gynecologic Investigations (2000 - Present)
Member, American Society of Gene Therapy (2000 - Present)
Member, Society of Gynecologic Oncology (2005 - Present)
Member, Gynecologic Oncology Group (2005 - Present)
Fellowship: UCLA Medical Center Obstetrics and Gynecology Fellowships (2005) CA
Residency: UCLA Medical Center Obstetrics and Gynecology Residency (1999) CA
Medical Education: University of Heidelberg (1989) Germany
Board Certification: American Board of Obstetrics and Gynecology, Gynecologic Oncology (2008)
Board Certification: American Board of Obstetrics and Gynecology, Obstetrics and Gynecology (2006)
PhD, University of California, Los Angeles, Molecular Biology (2003)
Residency: Ludwig Maximillians University (1992) Germany
Tel: (650) 724-0456
900 Blake Wilbur Dr
Palo Alto CA 94304
Tel: (650) 498-6004
Fax: (650) 498-7237
Get a Second Opinion
Directed Reading in Obstetrics and Gynecology
OBGYN 299 (Win, Spr)
Early Clinical Experience in Obstetrics and Gynecology
OBGYN 280 (Win, Spr)
Graduate Research in Reproductive Biology
OBGYN 399 (Win, Spr)
Medical Scholars Research
OBGYN 370 (Aut, Win, Spr, Sum)
Undergraduate Research in Reproductive Biology
OBGYN 199 (Win, Spr)
10 Results / Page
Profiles With Related Publications
Saul A. Rosenberg, MD, Professor of Lymphoma
Cancer > Lymphoma, Burkitt's Lymphoma, Hodgkin's Disease, Investigational Therapeutics, Lymphoma , Mycosis Fungoides, Non-Hodgkin's Lymphoma, Oncology (Cancer), Plasmacytoma, Waldenstrom's Macroglobulinemia , Medical Oncology
Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.
Jonathan S. Berek, MD, MMSc
Laurie Kraus Lacob Professor
Cancer > Gynecologic Cancer, Gynecologic Cancers - Gynecologic Oncology, Ovarian Cancer, Uterine Cancer, Uterine Cervical Cancer, Vaginal Cancer, Vulvar Cancer, Trophoblastic Neoplasms, Pelvic Reconstructive Surgery, Neovagina, Obstetrics and Gynecology
Robert W. Carlson
Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus
Clinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.
Christopher H. Contag
Professor of Pediatrics (Neonatology), Emeritus
We develop and use the tools of molecular imaging to understand oncogenesis, reveal patterns of cell migration in immunosurveillance, monitor gene expression, visualize stem cell biology, and assess the distribution of pathogens in living animal models of human biology and disease. Biology doesn't occur in "a vacuum" or on coated plates--it occurs in the living body and that's were we look for biological patterns and responses to insult.
Professor of Pathology and of Medicine (Immunology and Rheumatology)
Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine
Cancer > GI Oncology, Medical Oncology, Oncology, Cancer of the Pancreas, Colorectal Neoplasms, Neuroendocrine Tumors, gastro esophageal cancer, gastric cancer, stomach cancer, pancreatic neoplasms, small intestinal cancer, cholangiocarcinoma, bile duct cancer, gall bladder cancer, carcinoid tumor, appendiceal cancer, anal cancer
Clinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.
Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
Cancer > GI Oncology, Cancer Genetics, Gastrointestinal Cancers - Genetics, Gastrointestinal Cancers - Medical Oncology, Breast Cancer - Genetics, Ovarian Cancer - Genetics, Medical Oncology, Molecular Tumor Board
Mammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNAdamage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.
Amato J. Giaccia
Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology, Emeritus
During the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically.
Leonore A. Herzenberg
Department of Genetics Flow Cytometry Professor
B-cell lineage development and function; IgH rearrangement and repertoire analysis; HSC and lymphoid stem cells and lineages in mouse and man; T cell regulation of antibody responses; glutathione regulation of lymphoid and myeloid subst functions; development of advanced methods and software for Fluorescence-Activated Cell Sorting (FACS) and related analyses.
Clinical Professor, Obstetrics & Gynecology - Gynecologic Oncology
Cancer > Gynecologic Cancer, Gynecologic Oncology
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
Associate Professor of Radiation Oncology, Emerita
Cancer > Cutaneous (Dermatologic) Oncology, Cancer > Lymphoma, Cancer > Radiation Oncology, Radiation Oncology, Radiation Therapy, Lymphoma, Transplantation, Breast Cancer, Targeted Therapies
Our interests include 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, 3) the role of radiation in tumor vaccine strategies, 4) study of new radiosensitizers and radioprotectors, and 5) discovery of new targeted therapies for the treatment of solid tumors.
Publication Topics For This Person
Blood Flow Velocity
Cell Line, Tumor
Combined Modality Therapy
Disease Models, Animal
Drug Resistance, Neoplasm
Gene Transfer Techniques
Herpesvirus 4, Human
Transforming Growth Factor beta
Tumor Cells, Cultured